ProPhase Labs Q4 2023 Earnings Report $0.45 -0.01 (-2.61%) As of 04:00 PM Eastern Earnings HistoryForecast ProPhase Labs EPS ResultsActual EPS-$0.51Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AProPhase Labs Revenue ResultsActual Revenue$3.50 millionExpected Revenue$10.71 millionBeat/MissMissed by -$7.21 millionYoY Revenue GrowthN/AProPhase Labs Announcement DetailsQuarterQ4 2023Date3/28/2024TimeN/AConference Call ResourcesPRPH Earnings History ProPhase Labs Earnings HeadlinesProPhase Labs (NASDAQ:PRPH) Now Covered by Analysts at StockNews.comJanuary 26 at 3:45 AM | americanbankingnews.comProPhase Labs closes $23.6M sale of Pharmaloz ManufacturingJanuary 22, 2025 | markets.businessinsider.comUnlock the Secret to Microsoft's Yearly GainsWhat would you do if you knew that you could have placed a trade on Microsoft every year on October 13th … And had the chance to pocket an impressive gain in a matter of days… And this didn’t work just once… Not twice… But it worked for an entire decade… According to market veteran Jack Carter’s research, the recurring phenomenon generated winner after winner for 10 straight years! All you had to do is wait for October 13th to roll around on the calendar… Then place a quick trade… Of course, we can’t promise profits or prevent losses… But you can get 10 FREE trade ideas from Jack, just like that one on Microsoft.January 29, 2025 | Jack Carter Trading (Ad)ProPhase Labs Announces Closing of $23.6 Million Sale of Pharmaloz Manufacturing to Houston-Based Private Equity FirmJanuary 22, 2025 | markets.businessinsider.comProPhase Labs Stock Hits 52-Week Low at $0.56 Amid Market StrugglesJanuary 22, 2025 | msn.comProPhase Labs finalizing set of cost-saving measures for non-core operationsDecember 12, 2024 | markets.businessinsider.comSee More ProPhase Labs Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like ProPhase Labs? Sign up for Earnings360's daily newsletter to receive timely earnings updates on ProPhase Labs and other key companies, straight to your email. Email Address About ProPhase LabsProPhase Labs (NASDAQ:PRPH) develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.View ProPhase Labs ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Why Amazon’s Next Earnings Could Trigger a Stock BreakoutS&P 500 Earnings Set to Shine: January's Critical Market TestCiena Rebounds: AI and Strong Guidance Drive Post-Earnings SurgeHistory Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead? Upcoming Earnings Apple (1/30/2025)Comcast (1/30/2025)Intel (1/30/2025)KLA (1/30/2025)Sanofi (1/30/2025)Atlassian (1/30/2025)Arthur J. Gallagher & Co. (1/30/2025)Caterpillar (1/30/2025)The Cigna Group (1/30/2025)Canadian National Railway (1/30/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
